Trial Profile
To characterize the early utilization of Raltegravir QD in the United States from the OPERA® Observational Database
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Dec 2019
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Cobicistat/darunavir; Emtricitabine/tenofovir alafenamide; Emtricitabine/tenofovir disoproxil fumarate; Lamivudine/abacavir
- Indications HIV infections
- Focus Therapeutic Use
- 18 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018